Daniel Tuyet Kristensen, Rasmus Froberg Brøndum, Michael Knudsen, Marianne Tang Severinsen, Lykke Grubach, Mette Klarskov Andersen, Jack B. Cowland, Vibe Skov, Birgitte Preiss, Dorthe Ørnskov, Estrid Høgdall, Tim Svenstrup Poulsen, Eigil Kjeldsen, Marie Bill, Hans Beier Ommen, Andreas Due Ørskov, Claudia Schöllkopf, Jakob Werner Hansen, Kirsten Grønbæk, Claus Werenberg Marcher, Dennis Lund Hansen, Ole Halfdan Larsen, Martin Bøgsted, Anne Stidsholt Roug
{"title":"Outcomes and prognostic impact of trisomy 8 in acute myeloid leukemia patients treated with intensive chemotherapy","authors":"Daniel Tuyet Kristensen, Rasmus Froberg Brøndum, Michael Knudsen, Marianne Tang Severinsen, Lykke Grubach, Mette Klarskov Andersen, Jack B. Cowland, Vibe Skov, Birgitte Preiss, Dorthe Ørnskov, Estrid Høgdall, Tim Svenstrup Poulsen, Eigil Kjeldsen, Marie Bill, Hans Beier Ommen, Andreas Due Ørskov, Claudia Schöllkopf, Jakob Werner Hansen, Kirsten Grønbæk, Claus Werenberg Marcher, Dennis Lund Hansen, Ole Halfdan Larsen, Martin Bøgsted, Anne Stidsholt Roug","doi":"10.1038/s41408-025-01332-7","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":8989,"journal":{"name":"Blood Cancer Journal","volume":"27 1","pages":""},"PeriodicalIF":11.6000,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Cancer Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41408-025-01332-7","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
期刊介绍:
Blood Cancer Journal is dedicated to publishing high-quality articles related to hematologic malignancies and related disorders. The journal welcomes submissions of original research, reviews, guidelines, and letters that are deemed to have a significant impact in the field. While the journal covers a wide range of topics, it particularly focuses on areas such as:
Preclinical studies of new compounds, especially those that provide mechanistic insights
Clinical trials and observations
Reviews related to new drugs and current management of hematologic malignancies
Novel observations related to new mutations, molecular pathways, and tumor genomics
Blood Cancer Journal offers a forum for expedited publication of novel observations regarding new mutations or altered pathways.